Related references
Note: Only part of the references are listed.Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
Essack Mitha et al.
RHEUMATOLOGY (2013)
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
Robert A. Terkeltaub et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008
Yanyan Zhu et al.
ARTHRITIS AND RHEUMATISM (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Naomi Schlesinger et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
Kun Chen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
Chun-Jen Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The inflammatory process of gout and its treatment
Bruce N. Cronstein et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)